Page last updated: 2024-10-22

aristolochic acid i and Carcinoma

aristolochic acid i has been researched along with Carcinoma in 8 studies

aristolochic acid I: phospholipase A inhibitor
aristolochic acid A : An aristolochic acid that is phenanthrene-1-carboxylic acid that is substituted by a methylenedioxy group at the 3,4 positions, by a methoxy group at position 8, and by a nitro group at position 10. It is the most abundant of the aristolochic acids and is found in almost all Aristolochia (birthworts or pipevines) species. It has been tried in a number of treatments for inflammatory disorders, mainly in Chinese and folk medicine. However, there is concern over their use as aristolochic acid is both carcinogenic and nephrotoxic.

Carcinoma: A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for cancer.

Research Excerpts

ExcerptRelevanceReference
"Chinese herbs nephropathy (CHN) and Balkan endemic nephropathy (BEN) are chronic tubulointerstitial renal diseases associated with urothelial carcinoma."1.38Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy. ( De Broe, ME, 2012)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yang, HY2
Yang, CC1
Wu, CY1
Wang, LJ1
Lu, KL1
Chen, PC1
Wang, JD1
Kanaan, N1
Hassoun, Z1
Raggi, C1
Jadoul, M1
Mourad, M1
De Meyer, M1
Aydin, S1
Schmeiser, HH1
Cosyns, JP1
Goffin, E1
Kucab, JE1
Phillips, DH1
Arlt, VM1
Jelaković, B1
Karanović, S1
Vuković-Lela, I1
Miller, F1
Edwards, KL1
Nikolić, J1
Tomić, K1
Slade, N1
Brdar, B1
Turesky, RJ1
Stipančić, Ž1
Dittrich, D1
Grollman, AP2
Dickman, KG1
De Broe, ME1
Rosenquist, TA1
Hawkes, N1

Reviews

4 reviews available for aristolochic acid i and Carcinoma

ArticleYear
Aristolochic Acid and Immunotherapy for Urothelial Carcinoma: Directions for unmet Needs.
    International journal of molecular sciences, 2019, Jun-28, Volume: 20, Issue:13

    Topics: Animals; Aristolochic Acids; Carcinogens; Carcinoma; Humans; Immunotherapy; Urinary Bladder Neoplasm

2019
Chinese herbs containing aristolochic acid associated with renal failure and urothelial carcinoma: a review from epidemiologic observations to causal inference.
    BioMed research international, 2014, Volume: 2014

    Topics: Aristolochic Acids; Carcinogens; Carcinoma; DNA Adducts; Drugs, Chinese Herbal; Female; Humans; Occu

2014
Linking environmental carcinogen exposure to TP53 mutations in human tumours using the human TP53 knock-in (Hupki) mouse model.
    The FEBS journal, 2010, Volume: 277, Issue:12

    Topics: Animals; Aristolochic Acids; Benz(a)Anthracenes; Carcinogens, Environmental; Carcinoma; Environmenta

2010
Mutational signature of aristolochic acid: Clue to the recognition of a global disease.
    DNA repair, 2016, Volume: 44

    Topics: Alkylating Agents; Aristolochia; Aristolochic Acids; Carcinogens; Carcinoma; DNA Adducts; DNA Damage

2016

Other Studies

4 other studies available for aristolochic acid i and Carcinoma

ArticleYear
Long-term Outcome of Kidney Recipients Transplanted for Aristolochic Acid Nephropathy.
    Transplantation, 2016, Volume: 100, Issue:2

    Topics: Adult; Aged; Aristolochic Acids; Belgium; Carcinoma; Drug Therapy, Combination; Female; Graft Reject

2016
Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid.
    Kidney international, 2012, Volume: 81, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Aristolochic Acids; Balkan Nephropathy; Biomarkers; Biotransformatio

2012
Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy.
    Kidney international, 2012, Volume: 81, Issue:6

    Topics: Aristolochic Acids; Balkan Nephropathy; Carcinogens, Environmental; Carcinoma; DNA Adducts; Environm

2012
Herbal medicine might be responsible for high incidence of urinary tract cancer.
    BMJ (Clinical research ed.), 2012, Apr-10, Volume: 344

    Topics: Aristolochia; Biomarkers, Tumor; Body Mass Index; Carcinogens; Carcinoma; China; Drugs, Chinese Herb

2012